Friday Heads Up in the Diabetic Community!
Diabetes TalkFest, A Live Chat Site. On July 1, Diabetes TalkFest sponsored an online rally against insurance companies denying continuous glucose monitoring (CGMS).
DiabetesHealth, July 3, 2008. Diabetes Community Rallies Against Insurance Providers for Repeated Denials of LifeSaving Device
On Tuesday, July 1 online community Diabetes TalkFest sponsored the first CGMS Denial Day online rally highlighting the excessively high rate of denials issued by insurance companies for continuous glucose monitors. CGMS have been proven to help people with diabetes control their blood sugar levels, and quality of life. The event was held in association with social network site TuDiabetes.com.
Diabetes Headline News!
ScienceDaily, July 10, 2008. New Surgical Options for Treating Diabetic and Other Neuropathies Being Tested. “UT Southwestern Medical Center plastic surgeons and specialists in diabetes, neurology, pain management and rehabilitation are launching a cutting-edge study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with diabetic neuropathy.”
Medical News Today, July 10, 2008. Men With Diabetes Have More Sperm Damaged DNA. “Conference delegates in Spain yesterday heard about new research from Ireland that found diabetes in men had a direct effect on male fertility because of higher damage to sperm DNA.”
Wall Street Journal Market Watch, July 9, 2008. Major Studies on Mulberry Leaf Shows It’s Significant Promise For Millions of Americans Living With Type 2 Diabetes. “Major clinical trials conducted by a team of researchers and doctors at the University of Minnesota (Minneapolis VA Hospital), demonstrate that mulberry leaf, the food source of silkworms, can help markedly stabilize blood sugar levels and inhibit carbohydrate absorption in Type 2 diabetics by providing additional support which enables them to make better dietary and lifestyle choices.”
U.S. News & World Report, July 8, 2008. A Blood Marker Could Spot Diabetes Risk. “Rising levels of a blood protein called fetuin-A may indicate an elevated risk of developing type 2 diabetes, new research suggests.”